South Korea's first HIV-1/2 test to replace imports:
This article was originally published in Clinica
Executive Summary
Korea Green Cross has developed South Korea's first test for HIV-1/2, says Pharma Koreana. Production for the domestic market is due to begin shortly, replacing some Won 2,000 million ($2.6 million) of tests which are imported annually. Jointly developed by teams from Seoul National University's Genetic Engineering Institute and the Korea Institute of Science and Technology, Genedia HIV-1/2 is a third-generation ELISA-based test.